Skip to main content
. 2014 Apr 3;9(4):e93420. doi: 10.1371/journal.pone.0093420

Table 1. Summary findings of integrative omic analysis of endoxifen sensitivity in HapMap YRI LCLs.

Phenotype 3 μM 5 μM 7 μM 10 μM
Step1: pheno∼mRNA (p<0.05) 788 genes 897 genes 846 genes 1117 genes
Step2: pheno-miRNA (p<0.05) 32 miRNAs 71 miRNAs 74 miRNAs 94 miRNAs
Step3: mRNA∼miRNA (p≤0.0001) 13 miRNAs 33 miRNAs 45 miRNAs 56 miRNAs
28 genes 87 genes 95 genes 119 genes
Step 4: mRNA∼SNP (P≤0.0001) 28 genes 87 genes 95 genes 119 genes
18410 SNPs 45943 SNPs 47725 SNPs 45477 SNPs
Step 5: SNP∼miRNA (p<0.05) 13 miRNAs 33 miRNAs 45 miRNAs 56 miRNAs
9080 SNPs 33044 SNPs 35362 SNPs 36418 SNPs
Step 6: SNP∼pheno (p≤0.0001) 4 SNPs 22 SNPs 29 SNPs 23 SNPs
10 miRNAs 31 miRNAs 42 miRNAs 50 miRNAs
5 genes 84 genes 92 genes 117 genes
Final Associations 2 SNPs 16 SNPs 26 SNPs 11 SNPs
4 miRNAs 18 miRNAs 21 miRNAs 10 miRNAs
3 genes 14 genes 16 genes 13 genes

Six steps of associations among endoxifen sensitivity, SNP genotype, mRNA and miRNA expressions were conducted sequentially for 4 endoxifen treatment concentrations independently. Step 1, the association between the phenotypes of endoxifen sensitivity and ∼13,000 gene/transcript cluster expressions; step 2, the association between the phenotypes of endoxifen sensitivity and 201 miRNA expressions; step 3, the negative correlation between mRNA and miRNA expressions from step 1 and step 2; step 4, the association between mRNA expressions from step 3 and SNP genotypes; step 5, the association between miRNA expression from step 3 and SNP genotypes from step 4; step 6, the association of SNP genotypes from step 5 and the phenotypes of endoxifen sensitivity. The final associations are the SNP genotypes, mRNA and miRNA expressions from the step 6 that correlate with endoxifen sensitivity but also associate each other. Numbers of identified biomarkers were indicated in each step for each phenotype. “3, 5, 7 and 10 μM” represent phenotypes of the 4 concentrations of endoxifen treatment. “Pheno” represents the phenotypes of endoxifen sensitivity.